The U.S. Food and Drug Administration has cleared B. Braun Medical Inc.’s new hemodialyzer Diacap Pro, which the company said has improved clearance performance and user handling.

The new dialyzer has a lower comparable surface area and an increased molecule to surface contact.

“The newly developed fibers in Diacap Pro are designed to improve dialysis dose,” said Samuel Amory, Vice President at B. Braun Medical. “The Diacap Pro fibers clear blood toxins like urea and creatinine, while still retaining vital molecules like albumin.”

Diacap Pro is available in three sizes: 1.3m2, 1.6m2, 1.9m2.